instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'AMIODARONE'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the dosage of drug 'DIGOXIN'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the dosage of drug 'ESMOLOL HYDROCHLORIDE'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the dosage of drug 'FLECAINIDE'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the dosage of drug 'FUROSEMIDE'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the dosage of drug 'MILRINONE'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
What was the outcome of reaction 'Cardiac disorder'? | Epicardial Ablation of Persistent Junctional Reciprocating Tachycardia in an Infant With Tachycardia-Induced Cardiomyopathy.
A 3-month-old infant who developed persistent junctional reciprocating tachycardia (PJRT)-induced cardiomyopathy that was successfully treated with radiofrequency ablation. To our knowledge this ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317570 | 19,220,737 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE ACETATE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE ACETATE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac output decreased'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conduction disorder'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE ACETATE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device capturing issue'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Negative cardiac inotropic effect'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulseless electrical activity'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular dyssynchrony'. | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | FLECAINIDE | DrugsGivenReaction | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What is the weight of the patient? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | 92.3 kg. | Weight | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the administration route of drug 'FLECAINIDE'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the dosage of drug 'FUROSEMIDE'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | ESCALATING DOSES | DrugDosageText | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Bradycardia'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Brain injury'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Cardiac arrest'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Cardiac failure'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovering | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Cardiac output decreased'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Conduction disorder'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Device capturing issue'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Electrocardiogram QRS complex prolonged'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Negative cardiac inotropic effect'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Pulseless electrical activity'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
What was the outcome of reaction 'Toxicity to various agents'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,953 | 2021-04 |
What was the outcome of reaction 'Ventricular dyssynchrony'? | Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest.
An 86-year-old man with paroxysmal atrial fibrillation on flecainide, a class IC antiarrhythmic, presented with cardiac arrest. The patient had extremely wide QRS complexes with inconsistent pacemaker capture on electrocardiography. Due to car... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317582 | 19,011,843 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abscess'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 19,983,578 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aortic valve incompetence'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 19,983,578 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocarditis bacterial'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 20,044,858 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mitral valve incompetence'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 19,983,578 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 19,973,688 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Perforation'. | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34317610 | 19,983,578 | 2021-05 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317610 | 19,973,688 | 2021-05 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317610 | 19,994,301 | 2021-05 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | UNK, INDUCTION THERAPY FOR 3 DAYS WITH IV METHYLPREDNISOLONE (SOLUMEDROL) | DrugDosageText | CC BY-NC-ND | 34317610 | 19,983,578 | 2021-05 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Early Mitral Valve Repair Failure in the Setting of Endocarditis: When to Reoperate?
Surgery is recommended for endocarditis complicated by annular abscess or destruction of the native valve. Guidelines also recommend valvular repair over replacement for endocarditis when feasible. Guidance on management of early repai... | UNK (INDUCTION THERAPY WITH 3 DAYS) | DrugDosageText | CC BY-NC-ND | 34317610 | 19,994,301 | 2021-05 |
What was the administration route of drug 'HEPARIN SODIUM'? | A Cautionary Tale of Triple Therapy.
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy an... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317627 | 20,292,577 | 2021-05 |
What was the administration route of drug 'MILRINONE'? | A Cautionary Tale of Triple Therapy.
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy an... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317627 | 20,292,577 | 2021-05 |
What was the administration route of drug 'NOREPINEPHRINE'? | A Cautionary Tale of Triple Therapy.
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy an... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317627 | 20,292,577 | 2021-05 |
What was the outcome of reaction 'Drug interaction'? | A Cautionary Tale of Triple Therapy.
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317627 | 20,292,577 | 2021-05 |
What was the outcome of reaction 'Pericardial haemorrhage'? | A Cautionary Tale of Triple Therapy.
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34317627 | 20,292,577 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure acute'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chloroma'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular hypertrophy'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial effusion'. | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, FUROSEMIDE, METOPROLOL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
What was the administration route of drug 'FUROSEMIDE'? | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
What was the administration route of drug 'SPIRONOLACTONE'? | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
What was the outcome of reaction 'Cardiac failure acute'? | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
What was the outcome of reaction 'Chloroma'? | Cardiac Myeloid Sarcoma: A 1-kg Heart.
A 53-year-old man with a background of acute myelomonocytic leukemia in remission presented with pleurisy. Repeat transthoracic echocardiography over several weeks revealed thickening left ventricular walls and decreasing systolic function. He died of decompensated heart failure d... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317666 | 20,334,701 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Acute Myocardial Dysfunction and Hypereosinophilic Infiltrative Myocarditis Secondary to New-Onset Pediatric Acute Lymphoblastic Leukemia.
Myocardial infiltration by eosinophils leads to myocardial inflammation and fibrosis, resulting in restrictive hemodynamics. We describe an uncommon presentation of eosinophilic pre... | LISINOPRIL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 34317671 | 20,610,726 | 2021-07-07 |
What was the administration route of drug 'LISINOPRIL'? | Acute Myocardial Dysfunction and Hypereosinophilic Infiltrative Myocarditis Secondary to New-Onset Pediatric Acute Lymphoblastic Leukemia.
Myocardial infiltration by eosinophils leads to myocardial inflammation and fibrosis, resulting in restrictive hemodynamics. We describe an uncommon presentation of eosinophilic pre... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317671 | 20,610,726 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | ALBUTEROL, FORMOTEROL\MOMETASONE, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | ALBUTEROL, FORMOTEROL\MOMETASONE, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the administration route of drug 'ALBUTEROL'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the administration route of drug 'FORMOTEROL\MOMETASONE'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the dosage of drug 'ALBUTEROL'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | INHALER | DrugDosageText | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the dosage of drug 'FORMOTEROL\MOMETASONE'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | INHALER | DrugDosageText | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the outcome of reaction 'Cardiomyopathy'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | Recovering | ReactionOutcome | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
What was the outcome of reaction 'Cardiotoxicity'? | Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence.
Chronic use of hydroxychloroquine can result in cardiomyopathy and conduction disturbances. Here, we describe a case of hydroxychloroquine cardiotoxicity in a patient with heart failure with preserved ejection fra... | Recovering | ReactionOutcome | CC BY-NC-ND | 34317672 | 19,519,635 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella bacteraemia'. | LVAD Vasculitis Case Series: Suggestion of a New Fatal LVAD-Related Phenomenon.
Left ventricular assist devices (LVADs) are surgically implanted mechanical devices indicated for patients with advanced heart failure and are known to come with several complications. Here we present a case series, and review 1 documented ... | RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34317675 | 20,526,794 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | LVAD Vasculitis Case Series: Suggestion of a New Fatal LVAD-Related Phenomenon.
Left ventricular assist devices (LVADs) are surgically implanted mechanical devices indicated for patients with advanced heart failure and are known to come with several complications. Here we present a case series, and review 1 documented ... | RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34317675 | 20,526,794 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | LVAD Vasculitis Case Series: Suggestion of a New Fatal LVAD-Related Phenomenon.
Left ventricular assist devices (LVADs) are surgically implanted mechanical devices indicated for patients with advanced heart failure and are known to come with several complications. Here we present a case series, and review 1 documented ... | RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34317675 | 20,526,794 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stress cardiomyopathy'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.
A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a... | CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, MOGAMULIZUMAB-KPKC, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34317676 | 19,677,017 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
Tumoral obstruction is a small, but broadly defined, category of pulmonary hypertension that encompasses microvascular tumor emboli, tumor thrombotic microangiopathy, and macrovascular tumor ob... | CARBOPLATIN, GEMCITABINE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34317681 | 20,584,982 | 2021-07-07 |
What was the administration route of drug 'TREPROSTINIL'? | Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
Tumoral obstruction is a small, but broadly defined, category of pulmonary hypertension that encompasses microvascular tumor emboli, tumor thrombotic microangiopathy, and macrovascular tumor ob... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317681 | 20,530,271 | 2021-07-07 |
What was the outcome of reaction 'Condition aggravated'? | Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
Tumoral obstruction is a small, but broadly defined, category of pulmonary hypertension that encompasses microvascular tumor emboli, tumor thrombotic microangiopathy, and macrovascular tumor ob... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317681 | 20,530,271 | 2021-07-07 |
What was the outcome of reaction 'Off label use'? | Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
Tumoral obstruction is a small, but broadly defined, category of pulmonary hypertension that encompasses microvascular tumor emboli, tumor thrombotic microangiopathy, and macrovascular tumor ob... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317681 | 20,530,271 | 2021-07-07 |
What was the outcome of reaction 'Pulmonary veno-occlusive disease'? | Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
Tumoral obstruction is a small, but broadly defined, category of pulmonary hypertension that encompasses microvascular tumor emboli, tumor thrombotic microangiopathy, and macrovascular tumor ob... | Fatal | ReactionOutcome | CC BY-NC-ND | 34317681 | 20,530,271 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ischaemic'. | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | AMIODARONE, FLECAINIDE, LIDOCAINE HYDROCHLORIDE, MEXILETINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | AMIODARONE, FLECAINIDE, LIDOCAINE HYDROCHLORIDE, MEXILETINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low cardiac output syndrome'. | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | AMIODARONE, FLECAINIDE, LIDOCAINE HYDROCHLORIDE, MEXILETINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
What was the administration route of drug 'AMIODARONE'? | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
What was the administration route of drug 'FLECAINIDE'? | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
What was the administration route of drug 'LIDOCAINE HYDROCHLORIDE'? | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
What was the administration route of drug 'MEXILETINE'? | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
What was the administration route of drug 'PROPRANOLOL HYDROCHLORIDE'? | Successful Open Chest Epicardial Ablation for Refractory Ventricular Tachycardia in an LVAD Recipient.
A patient with history of dilated cardiomyopathy, a cardiac resynchronization therapy defibrillator, and endocardial ablation presented for refractory ventricular tachycardia 3 years after implantation of a Jarvik 200... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34317683 | 20,670,286 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Transaxillary Stenting of LVAD Outflow Graft Obstruction.
An 82-year-old man with a HeartMate II left ventricular assist device presented with low-flow alarms and cardiogenic shock secondary to left ventricular assist device outflow graft obstruction. Given high risk for redo sternotomy, the heart team decided on percu... | AMIODARONE, ASPIRIN, DIGOXIN, HYDRALAZINE HYDROCHLORIDE, SILDENAFIL, WARFARIN | DrugsGivenReaction | CC BY | 34317685 | 20,496,597 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular access site haematoma'. | Transaxillary Stenting of LVAD Outflow Graft Obstruction.
An 82-year-old man with a HeartMate II left ventricular assist device presented with low-flow alarms and cardiogenic shock secondary to left ventricular assist device outflow graft obstruction. Given high risk for redo sternotomy, the heart team decided on percu... | AMIODARONE, ASPIRIN, DIGOXIN, HYDRALAZINE HYDROCHLORIDE, SILDENAFIL, WARFARIN | DrugsGivenReaction | CC BY | 34317685 | 20,496,597 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Spontaneous Termination of Ventricular Fibrillation: Is Organization Required?
Ventricular fibrillation is a life-threatening arrhythmia that can result in sudden cardiac death and almost always requires emergency electrical defibrillation. This paper presents a unique case of a 74-year-old woman with spontaneous termi... | AMIODARONE, APIXABAN, PANTOPRAZOLE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34317692 | 19,609,278 | 2021-07-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular end-diastolic pressure increased'. | Spontaneous Termination of Ventricular Fibrillation: Is Organization Required?
Ventricular fibrillation is a life-threatening arrhythmia that can result in sudden cardiac death and almost always requires emergency electrical defibrillation. This paper presents a unique case of a 74-year-old woman with spontaneous termi... | AMIODARONE, APIXABAN, PANTOPRAZOLE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34317692 | 19,575,011 | 2021-07-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Syncope'. | Spontaneous Termination of Ventricular Fibrillation: Is Organization Required?
Ventricular fibrillation is a life-threatening arrhythmia that can result in sudden cardiac death and almost always requires emergency electrical defibrillation. This paper presents a unique case of a 74-year-old woman with spontaneous termi... | AMIODARONE, APIXABAN, PANTOPRAZOLE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34317692 | 19,609,278 | 2021-07-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular extrasystoles'. | Spontaneous Termination of Ventricular Fibrillation: Is Organization Required?
Ventricular fibrillation is a life-threatening arrhythmia that can result in sudden cardiac death and almost always requires emergency electrical defibrillation. This paper presents a unique case of a 74-year-old woman with spontaneous termi... | AMIODARONE, APIXABAN, PANTOPRAZOLE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34317692 | 19,609,278 | 2021-07-21 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.